Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Swiss National Bank

Gilead Sciences - Leader in HIV Medicines

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Swiss National Bank

Swiss National Bank decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,517,000 shares of the biopharmaceutical company’s stock after selling 180,900 shares during the quarter. Swiss National Bank’s holdings in Gilead Sciences were worth $324,865,000 as of its […]

Prologis, Inc. (NYSE:PLD) Shares Sold by Swiss National Bank

Swiss National Bank decreased its holdings in shares of Prologis, Inc. (NYSE:PLD – Free Report) by 4.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,615,708 shares of the real estate investment trust’s stock after selling 132,500 shares during the period. Swiss National Bank owned […]